Total Payments
$20,530
2024 Payments
$877.12
Companies
23
Transactions
105
Medicare Patients
2,597
Medicare Billing
$426,862
Payment Breakdown by Category
Consulting$12,125 (59.1%)
Food & Beverage$3,634 (17.7%)
Other$2,520 (12.3%)
Travel$2,147 (10.5%)
Education$104.34 (0.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $12,125 | 5 | 59.1% |
| Food and Beverage | $3,634 | 84 | 17.7% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $2,520 | 1 | 12.3% |
| Travel and Lodging | $2,147 | 13 | 10.5% |
| Education | $104.34 | 2 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Biom'Up SA | $6,872 | 14 | $0 (2019) |
| Dilon Technologies, Inc. | $4,499 | 8 | $0 (2024) |
| Merck Sharp & Dohme LLC | $2,699 | 9 | $0 (2023) |
| AbbVie Inc. | $2,640 | 2 | $0 (2020) |
| Intuitive Surgical, Inc. | $897.87 | 10 | $0 (2023) |
| Stryker Corporation | $850.03 | 11 | $0 (2023) |
| Eisai Inc. | $376.24 | 10 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $372.62 | 8 | $0 (2024) |
| GlaxoSmithKline, LLC. | $196.90 | 7 | $0 (2024) |
| Covidien LP | $187.71 | 5 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $877.12 | 23 | Dilon Technologies, Inc. ($210.53) |
| 2023 | $5,759 | 32 | Dilon Technologies, Inc. ($4,288) |
| 2022 | $244.01 | 9 | AstraZeneca Pharmaceuticals LP ($92.29) |
| 2021 | $86.41 | 2 | AstraZeneca Pharmaceuticals LP ($70.06) |
| 2020 | $2,625 | 1 | AbbVie Inc. ($2,625) |
| 2019 | $6,992 | 17 | Biom'Up SA ($6,872) |
| 2018 | $3,086 | 9 | Merck Sharp & Dohme Corporation ($2,545) |
| 2017 | $860.64 | 12 | Stryker Corporation ($681.29) |
All Payment Transactions
105 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/02/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | In-kind items and services | $27.67 | General |
| Category: Oncology | ||||||
| 11/21/2024 | Tempus AI, Inc | — | Food and Beverage | In-kind items and services | $28.23 | General |
| 11/07/2024 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $26.97 | General |
| Category: Oncology | ||||||
| 11/04/2024 | Dilon Technologies, Inc. | HEMOBLAST BELLOWS (Device) | Food and Beverage | In-kind items and services | $42.35 | General |
| Category: HEMOSTATIC AGENT | ||||||
| 11/04/2024 | PFIZER INC. | TIVDAK (Biological) | Food and Beverage | In-kind items and services | $20.64 | General |
| Category: Oncology | ||||||
| 10/07/2024 | Tempus AI, Inc | — | Food and Beverage | In-kind items and services | $19.07 | General |
| 10/03/2024 | Tempus AI, Inc | — | Food and Beverage | In-kind items and services | $22.71 | General |
| 10/03/2024 | Tempus AI, Inc | — | Food and Beverage | In-kind items and services | $14.56 | General |
| 09/26/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | In-kind items and services | $28.44 | General |
| Category: Oncology | ||||||
| 08/30/2024 | Tempus AI, Inc | — | Food and Beverage | In-kind items and services | $22.11 | General |
| 08/29/2024 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $22.27 | General |
| Category: Oncology | ||||||
| 08/22/2024 | GlaxoSmithKline, LLC. | ZEJULA (Drug) | Food and Beverage | In-kind items and services | $24.87 | General |
| Category: ONCOLOGY | ||||||
| 06/17/2024 | Dilon Technologies, Inc. | HEMOBLAST BELLOWS (Device) | Food and Beverage | In-kind items and services | $100.31 | General |
| Category: HEMOSTATIC AGENT | ||||||
| 06/13/2024 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $29.68 | General |
| Category: Oncology | ||||||
| 06/05/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | In-kind items and services | $27.67 | General |
| Category: Oncology | ||||||
| 05/22/2024 | GlaxoSmithKline, LLC. | JEMPERLI (Biological) | Food and Beverage | In-kind items and services | $72.12 | General |
| Category: ONCOLOGY | ||||||
| 05/20/2024 | PFIZER INC. | TIVDAK (Biological) | Food and Beverage | In-kind items and services | $16.82 | General |
| Category: Oncology | ||||||
| 05/08/2024 | GlaxoSmithKline, LLC. | ZEJULA (Drug) | Food and Beverage | In-kind items and services | $19.15 | General |
| Category: ONCOLOGY | ||||||
| 03/07/2024 | GlaxoSmithKline, LLC. | ZEJULA (Drug) | Food and Beverage | In-kind items and services | $22.59 | General |
| Category: ONCOLOGY | ||||||
| 03/06/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | Cash or cash equivalent | $108.50 | General |
| Category: Oncology | ||||||
| 02/28/2024 | Kerecis Limited | Kerecis Omega3 SurgiClose (Device), Kerecis Omega3 Marigen, Kerecis Omega3 Marigen | Food and Beverage | Cash or cash equivalent | $86.77 | General |
| Category: Wound Care | ||||||
| 02/06/2024 | Dilon Technologies, Inc. | HEMOBLAST BELLOWS (Device) | Food and Beverage | In-kind items and services | $67.87 | General |
| Category: HEMOSTATIC AGENT | ||||||
| 01/18/2024 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $25.75 | General |
| Category: Oncology | ||||||
| 12/15/2023 | Seagen Inc. | — | Education | In-kind items and services | $87.99 | General |
| 12/14/2023 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $31.74 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 631 | 740 | $455,907 | $107,180 |
| 2022 | 20 | 709 | 780 | $479,830 | $126,893 |
| 2021 | 15 | 632 | 744 | $348,498 | $99,212 |
| 2020 | 17 | 625 | 730 | $342,642 | $93,577 |
Total Patients
2,597
Total Services
2,994
Medicare Billing
$426,862
Procedure Codes
69
All Medicare Procedures & Services
69 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 58571 | Removal of uterus, tubes, and/or ovaries through abdomen using an endoscope, 250.0 g or less | Facility | 2023 | 57 | 57 | $119,261 | $34,160 | 28.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 230 | 282 | $50,389 | $12,233 | 24.3% |
| 58662 | Destruction or removal of ovary or growth of pelvis using an endoscope | Facility | 2023 | 29 | 29 | $47,769 | $11,507 | 24.1% |
| 57425 | Surgical repair of vaginal defect using an endoscope | Facility | 2023 | 16 | 16 | $39,056 | $11,175 | 28.6% |
| 38572 | Removal of lymph nodes of both sides of pelvis and abdominal lymph node biopsy using an endoscope | Facility | 2023 | 15 | 15 | $33,897 | $9,102 | 26.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 79 | 79 | $27,606 | $7,903 | 28.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 61 | 74 | $18,922 | $4,929 | 26.0% |
| 36561 | Insertion of central venous tube with port (5 years or older) | Facility | 2023 | 13 | 13 | $30,974 | $3,328 | 10.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 18 | 18 | $8,718 | $2,496 | 28.6% |
| 58558 | Biopsy of lining of uterus and/or removal of polyp using an endoscope | Facility | 2023 | 13 | 13 | $45,574 | $2,346 | 5.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 15 | 21 | $8,123 | $2,104 | 25.9% |
| 57200 | Suture of nonobstetrical injury of vagina | Facility | 2023 | 12 | 12 | $9,807 | $2,080 | 21.2% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 13 | 45 | $4,268 | $1,728 | 40.5% |
| 56605 | Biopsy of growth of external female genitals, first growth | Facility | 2023 | 20 | 24 | $4,524 | $999.75 | 22.1% |
| 57100 | Simple biopsy of vaginal mucous membrane | Facility | 2023 | 14 | 16 | $2,767 | $762.92 | 27.6% |
| 77001 | Fluoroscopic guidance for insertion or removal of central vein access device | Facility | 2023 | 13 | 13 | $3,063 | $181.48 | 5.9% |
| 76937 | Ultrasonic guidance for blood vessel access | Facility | 2023 | 13 | 13 | $1,189 | $144.95 | 12.2% |
| 58571 | Removal of uterus, tubes, and/or ovaries through abdomen using an endoscope, 250.0 g or less | Facility | 2022 | 67 | 67 | $129,076 | $40,850 | 31.6% |
| 58662 | Destruction or removal of ovary or growth of pelvis using an endoscope | Facility | 2022 | 39 | 39 | $59,078 | $15,955 | 27.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 230 | 262 | $48,429 | $11,158 | 23.0% |
| 38573 | Removal of lymph nodes of both sides of pelvis with biopsy and washing of abdomen using an endoscope | Facility | 2022 | 12 | 12 | $31,017 | $10,544 | 34.0% |
| 57425 | Surgical repair of vaginal defect using an endoscope | Facility | 2022 | 14 | 14 | $29,571 | $9,193 | 31.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 95 | 95 | $32,073 | $9,074 | 28.3% |
| 38572 | Removal of lymph nodes of both sides of pelvis and abdominal lymph node biopsy using an endoscope | Facility | 2022 | 18 | 18 | $35,481 | $8,878 | 25.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 63 | 74 | $19,249 | $5,107 | 26.5% |
About Dr. William Mcbee, MD
Dr. William Mcbee, MD is a Gynecology healthcare provider based in Morgantown, West Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/01/2007. The National Provider Identifier (NPI) number assigned to this provider is 1891997979.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. William Mcbee, MD has received a total of $20,530 in payments from pharmaceutical and medical device companies, with $877.12 received in 2024. These payments were reported across 105 transactions from 23 companies. The most common payment nature is "Consulting Fee" ($12,125).
As a Medicare-enrolled provider, Mcbee has provided services to 2,597 Medicare beneficiaries, totaling 2,994 services with total Medicare billing of $426,862. Data is available for 4 years (2020–2023), covering 69 distinct procedure/service records.
Ad
Practice Information
- Specialty Gynecology
- Other Specialties Gynecologic Oncology
- Location Morgantown, WV
- Active Since 06/01/2007
- Last Updated 12/14/2018
- Taxonomy Code 207VG0400X
- Entity Type Individual
- NPI Number 1891997979
Products in Payments
- HEMOBLAST (Device) $6,651
- HEMOBLAST BELLOWS (Device) $4,499
- GARDASIL (Biological) $2,545
- Da Vinci Surgical System (Device) $897.87
- vitagel (Device) $681.29
- LYNPARZA (Drug) $372.62
- Lenvima (Drug) $309.08
- KEYTRUDA (Biological) $285.10
- Hemoblast (Device) $220.45
- ZEJULA (Drug) $215.50
- EVICEL (Biological) $168.72
- 1588 HD 3 CHIP CAMERA (Device) $137.59
- V-Loc (Device) $117.58
- Kerecis Omega3 SurgiClose (Device) $86.77
- JEMPERLI (Biological) $72.12
- PREVENA (Device) $70.20
- TIVDAK (Biological) $67.29
- Edge (Device) $40.92
- LigaSure (Device) $29.21
- PreciseTumor (Device) $22.21
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.